Bushenhuoluo Decoction improves polycystic ovary syndrome by regulating exosomal miR-30a-5p/ SOCS3/mTOR/NLRP3 signaling-mediated autophagy and pyroptosis

Qun Huang,Yuanbin Li,Zhuang Chen,Huiping Ou,Yanjiao Tan,Hui Lin
DOI: https://doi.org/10.1186/s13048-024-01355-x
2024-02-03
Journal of Ovarian Research
Abstract:Polycystic ovary syndrome (PCOS) is a frequent and complicated endocrine disease that remains a major reason for infertility. Bushenhuoluo Decotion (BSHLD) has been validated to exhibit curative effects on PCOS. This study was aimed to explore the potential mechanism underlying the therapeutic action of BSHLD.
reproductive biology
What problem does this paper attempt to address?
This paper aims to explore the specific mechanisms by which Bushen Huoluo Decoction (BSHLD) improves granulosa cell autophagy and pyroptosis in polycystic ovary syndrome (PCOS) by regulating the exosomal miR-30a-5p/SOCS3/mTOR/NLRP3 signaling pathway. Specifically: - Research Background: Polycystic ovary syndrome is a common and complex endocrine disorder that leads to issues such as infertility. - Research Objective: To explore the potential mechanisms of BSHLD in the treatment of PCOS. - Research Findings: BSHLD can improve ovarian function in PCOS rats and inhibit excessive autophagy and pyroptosis. - Research Mechanism: BSHLD exerts its effects by reducing the expression of miR-30a-5p in serum, serum exosomes, and ovarian tissue, thereby affecting autophagy and pyroptosis-related signaling pathways.